Open in TheBrain

Conduritol

Overview of Conduritol

Conduritol refers to a group of organic compounds that can be viewed as derivatives of cyclohexene, where four hydroxyl groups replace hydrogen atoms on the four carbon atoms not adjacent to the double bond. These compounds are characterized by their chemical formula \(C_6H_{10}O_4\). The conduritol family includes several isomers, namely conduritols A through F, which exhibit a variety of structural forms due to the presence of meso forms and D,L pairs among them[4][2].

Isomers and Synthesis

The conduritol family consists of ten isomeric forms, with conduritols A and D being meso forms, and conduritols B, C, E, and F existing as D,L pairs. This diversity in isomeric forms contributes to the complexity and richness of the conduritol family in chemical studies and applications[2].

Significant efforts have been made in the synthesis of conduritol derivatives, particularly focusing on enantiopure forms. For instance, a general method for the synthesis of enantiopure conduritol C derivatives has been reported, highlighting the enantiocontrolled process involved in producing these specific derivatives[3]. Additionally, new and stereospecific syntheses for all conduritol isomers have been developed, starting from appropriate 1,3-cyclohexadiene derivatives, which underscores the ongoing research and development in the field of conduritol chemistry[9].

Applications and Significance

Conduritols have found applications in various fields, including medicinal chemistry and biological studies. One notable compound, Conduritol B epoxide, is identified as a Gcase inhibitor and is associated with a wide range of biological activities and potential therapeutic applications. It is involved in various biochemical pathways and processes, such as apoptosis, autophagy, cell cycle/DNA damage, and more, indicating its significance in research related to anti-infection, immunology, metabolic enzyme/protease, and neuronal signaling, among others[1].

The structural analysis of Conduritol B Epoxide has revealed its complex nature, including a pseudo-disaccharide Mn2+ chelate complex containing structures reminiscent of pinitol and galactosoamine. This highlights the intricate molecular architecture of conduritol derivatives and their potential for diverse biological interactions and applications[8].

Conclusion

Conduritols represent a fascinating group of organic compounds with significant chemical diversity and potential applications in various scientific and medicinal fields. The ongoing research into their synthesis, structural analysis, and biological activities continues to uncover new aspects of these compounds, contributing to our understanding of their roles and potential uses in science and medicine.

Citations:

[1] https://www.medchemexpress.com/Conduritol-B-epoxide.html

[2] https://www.sciencedirect.com/topics/chemistry/conduritol

[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100410/

[4] https://en.wikipedia.org/wiki/Conduritol

[5] https://www.caymanchem.com/product/15216/conduritol-b-epoxide

[6] https://pubs.acs.org/doi/10.1021/acs.joc.6b00616

[7] https://pubchem.ncbi.nlm.nih.gov/compound/Conduritol-A

[8] https://www.sciencedirect.com/topics/chemistry/conduritol-b-epoxide

[9] https://www.degruyter.com/document/doi/10.1351/pac199769010097/pdf

[10] https://www.ebi.ac.uk/chebi/chebiOntology.do?chebiId=CHEBI%3A67221

[11] https://www.enzolifesciences.com/BML-S104/conduritol-b-epoxide/

[12] https://pubmed.ncbi.nlm.nih.gov/27096579/

[13] https://www.ebi.ac.uk/chebi/ru/searchId.do%3B03B8AC5B7DF5D564D1376F80F13631DE?chebiId=67218&locale=null&printerFriendlyView=true&viewTermLineage=null

[14] https://www.sciencedirect.com/science/article/pii/S0040403900887973

[15] https://pubchem.ncbi.nlm.nih.gov/compound/Conduritol-B

[16] https://pubs.rsc.org/en/content/articlelanding/1988/c3/c39880001330

[17] https://en.wiktionary.org/wiki/conduritol

[18] https://pubs.acs.org/doi/10.1021/ja01112a043

[19] https://en.glosbe.com/en/en/conduritol

[20] https://pubs.rsc.org/en/content/articlelanding/1999/p1/a808329k

Attachments